Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of CDK2 and CDK5 Dual Degrader TMX‐2172

Angewandte Chemie(2020)10.1002/ange.202004087Source: DataRank Database

Development of CDK2 and CDK5 Dual Degrader TMX‐2172 is a research paper published in Angewandte Chemie (2020). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

5 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: closedTopics (12)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Jie Jiang ORCID,Zhixiang He ORCID,Nicholas Kwiatkowski ORCID,Katherine A. Donovan ORCID,Caitlin E. Mills ORCID

Live enrichment

PubMed:19767382

National Institutes of Health

Grant: R01CA218278

National Institutes of Health

Grant: P01CA154303

National Institutes of Health

Grant: 5U54HL127365-06

Pharmaco Response Signatures and Disease Mechanism

National Institutes of Health

Grant: 5R01CA218278-03

Degrading therapeutically important kinases using small molecules

National Institutes of Health

Grant: 5P01CA154303-09

Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma

closedLicense: Wiley Online Library User Agreement

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fange.202004087

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ange.202004087

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/ange.202004087

https://doi.org/10.1002/ange.202004087

https://doi.org/10.1002/anie.202004087

Fields of Study

0301 basic medicine03 medical and health sciences

Keywords

Ovarian NeoplasmsCell Line, TumorCyclin-Dependent Kinase 2HumansCyclin-Dependent Kinase 5FemaleDrug Screening Assays, AntitumorPhosphorylationProtein Kinase InhibitorsCell Division

Sustainable Development Goals

SDG 3: 3. Good health